Sierra Leone

in page functions
[French]
Sierra Leone
Total population (2018) 6,875,056
Birth cohort (2018) 232,927
Surviving Infants (surviving to 1 year per year, 2018) 214,382
Infant mortality rate (deaths < 1 year per 1000 births, 2015) 87/1000
Child mortality rate (deaths < 5 years per 1000 births, 2015) 120/1000
World Bank Index, IDA (2015) 3.27
Gross Nation Income (per capita US$, 2015) 620
Co-financing group (2018) Initial self-financing
No. of districts/territories (2017) 14

Contact Gavi

For more info, contact Gavi country representative officer or email here

Gavi support for Sierra Leone

Type of support

Approvals

2001-2023 (US$)
(28 Nov 2018)

Commitments

2001-2023 (US$)
(28 Nov 2018)

Disbursements

2000-2018 (US$)
(28 Nov 2018)

% Disbursed

(28 Nov 2018)
2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021
Total $83,174,256 $102,002,273 $72,531,412
Cash Support (CASHSUPP) $195,000 $195,000 $170,000 87%
Cold Chain Equipment Optimisation Platform (CCEOP) $1,302,611 $1,302,611 $1,301,914 100%
Ebola EPI Recovery Plan (EEPIRP) $3,819,373 $3,819,373 $3,819,373 100%
Health system strengthening (HSS 1) $1,161,447 $1,161,447 $1,161,447 100%
Health system strengthening (HSS 2) N/A
Health system strengthening (HSS 3) $8,852,983 $15,340,000 $5,012,345 57%
HPV (NVS) $1,155,000 $2,958,500
HPV Demo (NVS) $180,664 $180,664 $181,529 100%
Immunisation services support (ISS) $2,655,440 $2,655,440 $2,655,440 100%
Injection Safety Devices (NVS) $507,500 $791,000 $234,402 46%
Injection safety support (INS) $272,660 $272,660 $272,660 100%
IPV (NVS) $1,155,561 $1,155,561 $201,881 17%
Measles (NVS) $280,500 $280,500 $295,799 105%
MR 1st and 2nd dose (NVS) $192,500 $699,000
MR-Catch-up campaign (NVS) $2,370,000 $2,370,000
MR-Catch-up campaign op.costs (OPC) $2,005,044 $2,005,044
Penta (NVS) $17,927,437 $18,941,437 $17,619,666 98%
Pneumo (NVS) $28,453,476 $33,735,476 $30,525,395 107%
Product Switch Grant (PSG) $75,533 $75,533
Rotavirus (NVS) $5,889,161 $8,536,161 $5,134,926 87%
Vaccine Introduction Grant (VIG) $1,253,414 $1,253,414 $782,500 62%
Yellow Fever (NVS) $3,468,952 $4,273,452 $3,162,135 91%

Red line on table indicates duration of support based on commitments.
Commitments: Multi-year programme budgets endorsed in principle by the Gavi Board. These become financial commitments upon approval each year for the following calendar year.
Approvals: Total Approved for funding

Download data for commitments, approvals & disbursements in XLS format

Sierra Leone DTP3 / immunisation coverage

DTP3 - WHO/UNICEF estimates (2017)

Grade of confidence


N/A
DTP3 - Official country estimates (2017) 90%
M:F sex ratio at birth (2018) 1.02
Household survey: DTP3 coverage for male (2012) 77.80%
Household survey: DTP3 coverage for female (2012) 77.90%
Household survey: Last DTP3 survey (2012) 78%
% districts achieving > 80% DTP3 coverage (2017) 79%
% districts achieving < 50% DTP3 coverage (2017) 0%
MCV WHO/UNICEF estimates (2017) 80%

Breakdown of support

Non-vaccine support Vaccine support
21% 79%
$15,175,679 $57,355,733

Data refers to disbursed values, date as per above chart

Move mouse over graph for details

News and updates relating to Sierra Leone

29 November 2018

Gavi item

Gavi Board starts framing Alliance's approach to 2021-2025 period

Gavi Board approves in principle a set of new and expanded vaccine programmes.

26 July 2018

Fragile states - Rohingya refugee camp

Children in fragile states missing out on lifesaving vaccines

New vaccination figures show millions more children being immunised in world’s poorest countries.

19 May 2018

Ebola Q&A thumb

DR Congo Ebola outbreak response: Q&A with Gavi CEO Dr Seth Berkley

Gavi CEO Dr Seth Berkley answers questions about the planned deployment of Merck’s rVSV-ZEBOV vaccine to counter the ongoing Ebola outbreak in the north west of the Democratic Republic of the Congo (DRC).

Disclaimer: the boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of Gavi, the Vaccine Alliance concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement.

close icon

modal window here